Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib

類似資料

• Modulation of the Antitumor Activity of Metronomic Cyclophosphamide by the Angiogenesis Inhibitor Axitinib
  著者:: Ma, Jie, 等
  出版事項: (2008)
• Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
  著者:: Hu, D E, 等
  出版事項: (1995)
• Combination of Anti-angiogenesis with Chemotherapy for More Effective Cancer Treatment
  著者:: Ma, Jie, 等
  出版事項: (2008)
• Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents
  著者:: Wang, Jinfeng, 等
  出版事項: (2017)
• Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
  著者:: Qin, Shuang, 等
  出版事項: (2019)